Statistics for Poolbeg Pharma PLC (id:4095 POLB)

Valuation metrics

Market cap

38.96M

Enterprise value

27.94M

Trailing P/E (ttm)

-981.01

Forward P/E

-0.06

PEG ratio

-0.06

Price/Sales (ttm)

Price/Book (mrq)

304.00

Enterprise Value/Revenue

Enterprise Value/EBITDA

-5.47

Overview

Shares outstanding

500.00M

Float

423.45M

Shares short

% Held by insiders

0.25%

% Held by institutions

0.01%

Average volume (10 days)

994.03K

Average volume (90 days)

Price summary

52-Week low

7.05

52-Week high

15.77

52-Week change

-26.45%

Beta

2.14

50-Day moving average

8.77

200-Day moving average

11.02

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-21.33%

Return on equity

-30.18%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-5,106,000.00

Net income to common (ttm)

-4,378,000.00

Diluted EPS (ttm)

-0.01

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

10.06M

Total cash per share (mrq)

0.02

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

1.96K%

Book value per share (mrq)

0.02

Cash flow

Cash flow statement

-4,360,000.00

Levered free cash flow (LFCF)

-3,241,500.00